Showing results (51-60 of 165) with videos related to
Sort By:
Pageof 17
Cardiovascular Drugs and Therapy|February 1, 1990
Renal effects of angiotensin converting enzyme inhibitors: nondiabetic chronic renal diseaseJ A Opsahl, P A Abraham, W F KeaneHypertension (Dallas, Tex. : 1979)|January 1, 1992
The Zucker rat model of obesity, insulin resistance, hyperlipidemia, and renal injuryB L Kasiske, M P O'Donnell, W F KeaneAmerican Journal of Hypertension|January 1, 1989
Risk factors for glomerular injury in rats with genetic hypertensionM P O'Donnell, B L Kasiske, W F KeaneThe American Journal of Physiology|May 1, 1989
Fish oil diet decreases prostacyclin and increases resistance in isolated rat kidneysB L Kasiske, M P O'Donnell, W F KeaneAntimicrobial Agents and Chemotherapy|January 1, 1984
Hemodialysis elimination rates and clearance of gentamicin and tobramycinG R Matzke, C E Halstenson, W F KeanePeritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|January 1, 1991
Antimicrobial treatment of peritonitis associated with continuous ambulatory peritoneal dialysisS P Millikin, G R Matzke, W F KeaneThe American Journal of Pathology|February 1, 1987
Mechanism of Escherichia coli alpha-hemolysin-induced injury to isolated renal tubular cellsW F Keane, R Welch, G Gekker, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 13, 2001
The CHORUS (Cerivastatin in Heart Outcomes in Renal Disease: Understanding Survival) protocol: a double-blind, placebo-controlled trial in patients with esrdW F Keane, B M Brenner, A Mazzu, et al.The American Journal of Medicine|August 1, 1976
Irreversible acute renal failure in idiopathic nephrotic syndromeL Raij, W F Keane, A Leonard, et al.Kidney International. Supplement|October 1, 1992
Is the aggressive management of hyperlipidemia in nephrotic syndrome mandatory?W F Keane, J V St Peter, B L KasiskePageof 17